Fingerprint
Dive into the research topics of 'Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically